期刊文献+

HLA-Ⅱ类基因与硬皮病的相关性研究进展 被引量:2

暂未订购
导出
作者 朱薇 严煜林
出处 《广西医学》 CAS 2007年第11期1730-1732,共3页 Guangxi Medical Journal
  • 相关文献

参考文献20

  • 1戴冽.硬皮病的诊断[J].新医学,2004,35(2):126-127. 被引量:7
  • 2肖嵘,赵会平,刘伏友,文海泉.硬皮病的病因及发病机制的研究进展[J].中国皮肤性病学杂志,2005,19(6):371-373. 被引量:7
  • 3Schwartz DW,Felser B,Mayr WR.The geneties of HLA[J].Folia Biol,1995,41 (3 -4):123-139.
  • 4Benham A,Tulp A,Neefjes J.Synthesis and assembly of MHC-peptide complexes[J].Immunol Today,1995,16(7):359 -362.
  • 5Du YP,Deng CS,Lu DY,Huang MF,Guo SF,Hou W.The relation between HLA-DQA1 genes and genetic susceptibility to duodenal ulcer in Wuhan Hans[J].World Journal of Gastroenterology,2000,6(1):107-110. 被引量:38
  • 6Kallenberg CG,Vander Voort-Beelen JM,D'Amaro J,et al.Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response[J].Clin Exp Immunol,1981,43 (3):478-485.
  • 7Alarcon GS,Phillips RM,WasnerCK,et al.DR antigens in systemic sclerosis:lack of clinical correlations[J].Tissue Antigens,1985,26(2):156 -158.
  • 8Vargas-Alarcon G,Granados J,Ibanez de Kasep G,et al.Association of HLA-DR5 (DR11) with systemic sclerosis (scleromerda) in Mexican patients[J].Clin Exp Rheumstol,1995,13(1):11 -16.
  • 9Tzkeuchi F,Nakano K,Yamada H,et al.Association of HLA-DR with progressive systemic sclerosis in Japanese[J].J Rheumatol,1994,21 (5):857 -863.
  • 10Joung CI,Jun JB,Chung WT,et al,Association between the HLA-DRB1 gene and clinical features of systemic sclerosis in Korea[J].Scandinavian Journal of Rheumatology,2006,35 (1):39-43.

二级参考文献40

  • 1Takeda K, Hatamochi A, Uekj H,et al. Decreased collagenase expression in cultured systemic sclerosis fibroblasts [ J ]. J Invest Dermatol, 1994,103 ( 3 ) :359 - 363.
  • 2Yazawa N, Kikuchi K, Hironobu I,et al. Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis[J]. J Am Acad Dermatol,2000,42( ⅠptⅠ ) :70 -75.
  • 3Young-Min SA, Beeton C, Laughton R,et al.Serum T1MP-1, TIMP-2 and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon and in normal controls[ J ]. Ann Rheum Dis, 2001,60 (9) :846 - 851.
  • 4Kuroda K, Shinkai H. Gene expression of types Ⅰ and Ⅲ collagen, deeorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis [ J ]. Arch Dermatol Res , 1997,289 ( 10 ) :567 - 572.
  • 5Yazawa N, Kikuchi K, lhn H,et al. Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis [ J ]. J Am Acad Dermatol,2000,42( Ⅰ pt Ⅰ ) :70- 75.
  • 6Sato S, Hayakawa I, Hasegawa M, et al.Function blocking autoantibodies against matrix metalloproteinase-Ⅰin patients with systemic sclerosis[ J ]. J Invest Dermatol,2003,120(4) :542 -547.
  • 7Karukonda SR, Flynn TC, Boh EE, et al.The effects of drugs on wound healing: part Ⅰ[J]. Int J Dermatol, 2000, 39 (4) : 250 -257.
  • 8Mcgaha T,Saito S,Phelps RG,et ttl. Lack of skin fibrosis in tight skin ( TSK ) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes[J], J Invest Dermatol,2001 , 116 ( 1 ) : 136- 143.
  • 9Smith P, Mosiello G, Deluca L, et al. TGF-β2 activates proliferative [ J ]. J Surg Res,1999,82(2) :319 -323.
  • 10Jelaska A, Korn JH. Role of apoptosis and transforming growthfactor betal in fibroblast selection and activation in systemic sclerosis[J]. Arthritis Rheum, 2000,43 ( 10 ) :2230- 2239.

共引文献49

同被引文献25

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部